Skip to main content

Table 1 Demographic characteristics of study participants

From: Assessing the impact of multidrug-resistant tuberculosis in children: an exploratory qualitative study

Participant age & identifier*

Sex

Ethnicity

HIV status

Duration of hospital admission

Younger children (age 5-10 years at start of MDR-TB treatment)

7a

F

Black

Negative

3 months, 6 days

7b

F

Black

Positive

NA

8

F

Coloured

Negative

5 months, 21 days

9a

F

Black

Positive

7 months, 5 days

9b

F

Coloured

Negative

NA

10

F

Black

Positive

5 months, 9 days

11a

F

Coloured

Negative

NA

11b

F

Black

Negative

5 months, 7 days

11c

F

Coloured

Positive

13 months, 4 days

11d

F

Coloured

Negative

4 months, 1 day

11e

F

Black

Negative

4 months

12

F

Coloured

Negative

3 months, 18 days

Older children (age ≥10 years at start of MDR-TB treatment)

14a

M

Black

Positive

3 months, 24 days

14b

M

Black

Negative

6 months, 28 days

15a

M

Black

Positive

19 months, 25 days

15b

M

Black

Positive

4 months, 27 days

15c

M

Coloured

Negative

2 months

17a

F

Coloured

Positive

8 months, 3 days

17b

F

Coloured

Negative

1 month, 18 days

17c

M

Black

Positive

1 month, 28 days

  1. Abbreviations: F Female, HIV Human immunodeficiency virus, M Male, MDR Multidrug-resistant tuberculosis, NA Not admitted, received outpatient treatment.
  2. *Unique identifiers were assigned to all participants. For example: “7a” refers to Child age 7, participant “a.” Ages are reported at the time of interview.
  3. †Self-reported: admission/discharge dates unavailable.